Qunye He - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Qunye He

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

International Journal of Biological Macromolecules|August 10, 2024

Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancersYijia Min, Yu Chen, Lei Wang, et al.

Theranostics|January 16, 2025

A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatmentLei Wang, Yong Ke, Qunye He, et al.

Journal of Experimental & Clinical Cancer Research : CR|June 19, 2024

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancerJiawei Zhang, Junjun Liu, Yali Yue, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

International Journal of Biological Macromolecules|August 10, 2024

Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancersYijia Min, Yu Chen, Lei Wang, et al.

Theranostics|January 16, 2025

A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatmentLei Wang, Yong Ke, Qunye He, et al.

Journal of Experimental & Clinical Cancer Research : CR|June 19, 2024

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancerJiawei Zhang, Junjun Liu, Yali Yue, et al.

Pageof 2